Tampa, Florida. A big step ahead in Covid-19 Remedy and an advance for a Florida-free-profit bloodstream that serves southeast.
Oneblood only the first blood medium to obtain the complete approval of the FDA to donate the convalescent plasma COVID-19 to a high-level name of other people who have recovered from Covid-19 to those who are COVID-19 that are also Immunocompromised.
“This license is something new and very important, especially for the ten million people in the United States who are immunosuppressed and can benefit from this,” said Dr. Rita Reik, Chief Medical Officer of OneBlood.
Dr. Reik explained that, at the beginning of the pandemic, they used convalescent plasma as a remedy in an emergency authorization, and now, five years later, they have enough knowledge for all this FDA approval.
“This plasma is collected from other people who have had covid, and have recovered, and are now healthy and meet all the criteria for a blood donor, yet they have a very high point of anti-Covid antibodies in their plasma. You can check this and verify that it’s a big antibody toppoint. And when we give that plasma to the user who is immunocompromised, they get the same or at least similar coverage opposite to the virus that the healthy donor has developed. “
Dr. David Sullivan is a professor and researcher at Johns Hopkins Bloomberg School of Public Health. ABC Action News asked him how this treatment will directly impact people with compromised immune systems.
“A lot of them are fearful of still resuming their normal pre-COVID lives,” said Dr. Sullivan. “They can’t be completely worry-free, but I think it does lessen the worries knowing that they have an antibody therapy to possibly combine with drug therapy, so if they get it, they don’t have to be so fearful of their lives.”
“Oneblood has actively worried about this since the first component of the pandemic. We gave our first PCCH emergency unit in April 2020, “said Dr. Reik. ” Being the last user in the relay race led by the stick of the final line and obtains the license is very rewarding for us. “
Inform a typographic error